Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial von Pagan, Fernando. L, Hebron, Michaeline L, Wilmarth, Barbara, Torres-Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E, Yusuf, Nadia, Starr, Nathan J, Anjum, Muhammad, Arellano, Joy, Howard, Helen H, Shi, Wangke, Mulki, Sanjana, Kurd-Misto, Tarick, Matar, Sara, Liu, Xiaoguang, Ahn, Jaeil, Moussa, Charbel

Volltext

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease von Pagan, Fernando L., Wilmarth, Barbara, Torres‐Yaghi, Yasar, Hebron, Michaeline L., Mulki, Sanjana, Ferrante, Dalila, Matar, Sara, Ahn, Jaeil, Moussa, Charbel

Volltext

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods von Pahwa, Rajesh, Pagan, Fernando L., Kremens, Daniel E., Saint-Hilaire, Marie

Volltext

Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier? von Isaacson, Stuart H., Pagan, Fernando L., Lew, Mark F., Pahwa, Rajesh

Volltext

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies von Pagan, Fernando L., Torres‐Yaghi, Yasar, Hebron, Michaeline L., Wilmarth, Barbara, Turner, R. Scott, Matar, Sara, Ferrante, Dalila, Ahn, Jaeil, Moussa, Charbel

Volltext

Improving outcomes through early diagnosis of Parkinson's disease von Pagan, Fernando L

Volltext

Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’... von Soileau, Michael J., Pagan, Fernando L., Fasano, Alfonso, Rodriguez-Cruz, Ramon, Yan, Connie H., Gupta, Niodita R., Teigland, Christie L., Pulungan, Zulkarnain, Schinkel, Jill K., Kandukuri, Prasanna L., Ladhani, Omar A., Siddiqui, Mustafa S.

Volltext

On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson’s Disease Psychosis von Pagan, Fernando L., Schulz, Paul E., Torres-Yaghi, Yasar, Pontone, Gregory M.

Volltext

Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases von Fowler, Alan J, Hebron, Michaeline, Balaraman, Kaluvu, Shi, Wangke, Missner, Alexander A, Greenzaid, Jonathan D, Chiu, Timothy L, Ullman, Clementina, Weatherdon, Ethan, Duka, Val, Torres-Yaghi, Yasar, Pagan, Fernando L, Liu, Xiaoguang, Ressom, Habtom, Ahn, Jaeil, Wolf, Christian, Moussa, Charbel

Volltext

Can sex influence the neurocognition of language? Evidence from Parkinson's disease von Reifegerste, Jana, Estabrooke, Ivy V., Russell, Lauren E., Veríssimo, João, Johari, Karim, Wilmarth, Barbara, Pagan, Fernando L., Moussa, Charbel, Ullman, Michael T.

Volltext

Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease von Pagan, Fernando L., Hebron, Michaeline L., Wilmarth, Barbara, Torres‐Yaghi, Yasar, Lawler, Abigail, Mundel, Elizabeth E., Yusuf, Nadia, Starr, Nathan J., Arellano, Joy, Howard, Helen H., Peyton, Margo, Matar, Sara, Liu, Xiaoguang, Fowler, Alan J., Schwartz, Sorell L., Ahn, Jaeil, Moussa, Charbel

Volltext

Combination targeting of subthalamic nucleus and ventral intermediate thalamic nucleus with a single trajectory in deep brain stimulation for tremor-dominant Parkinson’s disease von Fayed, Islam, Cobourn, Kelsey D., Pivazyan, Gnel, Torres-Yaghi, Yasar A., Pagan, Fernando L., Lo, Steven E., Mandir, Allen S., Kalhorn, Christopher G.

Volltext

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease von Fowler, Alan J., Ahn, Jaeil, Hebron, Michaeline, Chiu, Timothy, Ayoub, Reem, Mulki, Sanjana, Ressom, Habtom, Torres-Yaghi, Yasar, Wilmarth, Barbara, Pagan, Fernando L., Moussa, Charbel

Volltext

Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor von Isaacson, Stuart H, Peckham, Elizabeth, Tse, Winona, Waln, Olga, Way, Christopher, Petrossian, Melita T, Dahodwala, Nabila, Soileau, Michael J, Lew, Mark, Dietiker, Cameron, Luthra, Nijee, Agarwal, Pinky, Dhall, Rohit, Morgan, John, Calakos, Nicole, Zesiewicz, Theresa A, Shamim, Ejaz A, Kumar, Rajeev, LeWitt, Peter, Shill, Holly A, Simmons, Adam, Pagan, Fernando L, Khemani, Pravin, Tate, Jessica, Maddux, Brian, Luo, Lan, Ondo, William, Hallett, Mark, Rajagopal, Apoorva, Chidester, Paula, Rosenbluth, Kathryn H, Delp, Scott L, Pahwa, Rajesh

Volltext

A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin® : A new botulinum neurotoxin A von Pagan, Fernando L, Harrison, Andrew

Volltext

A Screening Tool to Identify Spasticity in Need of Treatment von Zorowitz, Richard D, Wein, Theodore H, Dunning, Kari, Deltombe, Thierry, Olver, John H, Davé, Shashank J, Dimyan, Michael A, Kelemen, John, Pagan, Fernando L, Evans, Christopher J, Gillard, Patrick J, Kissela, Brett M

Volltext

Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy von PAGAN, Fernando L, BUTMAN, John A, DAMBROSIA, James M, HALLETT, Mark

Volltext

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A von Mills, Reversa R, Pagan, Fernando L

Volltext

Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy von Espay, Alberto J, Pagan, Fernando L, Walter, Benjamin L, Morgan, John C, Elmer, Lawrence W, Waters, Cheryl H, Agarwal, Pinky, Dhall, Rohit, Ondo, William G, Klos, Kevin J, Silver, Dee E

Volltext

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study von Olanow, C Warren, Prof, Kieburtz, Karl, MD, Odin, Per, MD, Espay, Alberto J, MD, Standaert, David G, MD, Fernandez, Hubert H, MD, Vanagunas, Arvydas, MD, Othman, Ahmed A, PhD, Widnell, Katherine L, MD, Robieson, Weining Z, PhD, Pritchett, Yili, PhD, Chatamra, Krai, PhD, Benesh, Janet, BSMT, Lenz, Robert A, MD, Antonini, Angelo, MD

Volltext